With Senn's expertise and infrastructure, Granules aims to scale up its innovation capabilities and diversify its portfolio into complex and next-gen therapeutics.

Granules India completes aquisition of Swiss- based CDMO, Senn Chemicals: Our Bureau, Mumbai Friday, April 11, 2025, 12:10 ...

Granules India acquires Senn Chemicals AG, a Swiss CDMO specializing in peptide development, expanding into peptide ...

Chemists from HSE University and the Nesmeyanov Institute of Organoelement Compounds of the Russian Academy of Sciences (INEOS RAS) have developed a new method for synthesising amides, essential ...

HYDERABAD, India, April 03, 2025 (GLOBE NEWSWIRE) -- Sai Life Sciences Limited (BSE: 544306 I NSE: SAILIFE), an innovator-focused Contract Research, Development, and Manufacturing Organization (CRDMO) ...

Granules India has completed its acquisition of Senn Chemicals AG, a Switzerland-based contract development and manufacturing ...

The acquisition follows the signing of a definitive share purchase agreement in February 2025, under which Granules, through its wholly owned Indian subsidiary, Granules Peptides, acquired 100% of the ...